Enavatuzumab, a Humanized Anti-TWEAK Receptor Monoclonal Antibody, Exerts Antitumor Activity through Attracting and Activating Innate Immune Effector Cells

about

Enavatuzumab, a Humanized Anti-TWEAK Receptor Monoclonal Antibody, Exerts Antitumor Activity through Attracting and Activating Innate Immune Effector Cells

Item

http://www.wikidata.org/entity/Q42718215

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Enavatuzumab, a Humanized Anti ...... g Innate Immune Effector Cells

@en

Enavatuzumab, a Humanized Anti ...... g Innate Immune Effector Cells

@nl

type

Item

label

Enavatuzumab, a Humanized Anti ...... g Innate Immune Effector Cells

@en

Enavatuzumab, a Humanized Anti ...... g Innate Immune Effector Cells

@nl

prefLabel

Enavatuzumab, a Humanized Anti ...... g Innate Immune Effector Cells

@en

Enavatuzumab, a Humanized Anti ...... g Innate Immune Effector Cells

@nl

P1476

Enavatuzumab, a Humanized Anti ...... g Innate Immune Effector Cells

@en

P2093

Donghee Choi

http://www.w3.org/2001/XMLSchema#string

Mien Sho

http://www.w3.org/2001/XMLSchema#string

Nicole A Belmar

http://www.w3.org/2001/XMLSchema#string

Patricia A Culp

http://www.w3.org/2001/XMLSchema#string

Stephen F Keller

http://www.w3.org/2001/XMLSchema#string

Vivian Zhao

http://www.w3.org/2001/XMLSchema#string

Yuni Fang

http://www.w3.org/2001/XMLSchema#string

P2860

A novel TNF receptor family member binds TWEAK and is implicated in angiogenesis

Fc-dependent depletion of tumor-infiltrating regulatory T cells co-defines the efficacy of anti-CTLA-4 therapy against melanoma

The Fn14 immediate-early response gene is induced during liver regeneration and highly expressed in both human and murine hepatocellular carcinomas

The human Fn14 receptor gene is up-regulated in migrating glioma cells in vitro and overexpressed in advanced glial tumors

Multiple pathways of TWEAK-induced cell death

TWEAK, a new secreted ligand in the tumor necrosis factor family that weakly induces apoptosis

A Bioinformatics Resource for TWEAK-Fn14 Signaling Pathway

CD40 agonists alter tumor stroma and show efficacy against pancreatic carcinoma in mice and humans

Fcgamma receptors as regulators of immune responses

An Fcγ receptor-dependent mechanism drives antibody-mediated target-receptor signaling in cancer cells.

P304

5737159

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2017/5737159

http://www.w3.org/2001/XMLSchema#string

P478

2017

http://www.w3.org/2001/XMLSchema#string

P50

P577

2017-09-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29075649

http://www.w3.org/2001/XMLSchema#string

P932

5623805

http://www.w3.org/2001/XMLSchema#string